Term ends Dec 21, 2035 · High confidence
20-year base term ends Dec 21, 2035
Held by Novartis Pharma AG
Filed Sep 3, 2024 as application 18/823,573 · Granted May 13, 2025
Base term, 20 years from filing
Today
2015
2035
Clock starts
Dec 21, 2015
Dec 21, 2015
Term ends
Dec 21, 2035
Dec 21, 2035
Granted
May 13, 2025
May 13, 2025
base term
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 11,801,300, to Dec 21, 2035. The term already ends on or before that date, so the cap shortened nothing.
0 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
10
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 0 of 2 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 21, 2015, when application PCT/IB2015/059836, the earliest non-provisional in its chain, was filed (this one was filed Sep 3, 2024) | Dec 21, 2035 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 11,801,300) | resolves to Dec 21, 2035, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Dec 21, 2035 | High confidence |
This family
| US 11,801,300 | In force Dec 2035 | Dec 2035 |
| US 12,599,664 | In force Jan 2036 | Jan 2036 |
| US 12,296,008 | this patent Dec 2035 | Dec 2035 |
| US 12,485,173 | In force Dec 2035 | Dec 2035 |
| US 12,485,172 | In force Dec 2035 | Dec 2035 |
| US 12,544,438 | In force Dec 2035 | Dec 2035 |
| US 12,702,711 | In force Dec 2035 | Dec 2035 |
| US 12,741,024 | In force Dec 2035 | Dec 2035 |
8 of 10 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 19, 2025 Reel 70254, frame 919 | Joerg, Susanne; Serno-schersch, Kathrin | Novartis Pharma AG | Assignment of Assignor's Interest |
| Feb 19, 2025 Reel 70255, frame 416 | Novartis Pharma AG | Novartis AG | Assignment of Assignor's Interest |
| Jun 11, 2026 Reel 75712, frame 291 | Novartis AG | Novartis Pharma AG | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Dec 2035
Term ends Dec 21, 2035. Maintenance fees still fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 11,801,300, ends no earlier than this term, so it caps nothing.
Citations
0
later US patents cite this one
Fewer than half of the utility patents granted in 2025 in our data have been cited yet, so we show the count and do not rank on it.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.